Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftolozane/Tazobactam vs Meropenem for Febrile Neutropenia (CLEMENT)
NCT06342115Phase 4Recruiting
- Sponsor
- BP - A Beneficência Portuguesa de São Paulo
- Start
- Mar 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ceftolozane + tazobactam in febrile neutropenia (FN), sponsored by BP - A Beneficência Portuguesa de São Paulo. Started Mar 2025; status: recruiting.
02
Drugs
ceftolozane + tazobactam
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT06342115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06342115.